Class information for:
Level 1: METHAMPHETAMINE//MOL NEUROPSYCHIAT SECT//MOL NEUROPSYCHIAT BRANCH

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
2496 2155 45.2 74%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
2774 2623 METHAMPHETAMINE//CEREBROLYSIN//SURG SCI ANESTHESIOL INTENS CARE MED

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 METHAMPHETAMINE Author keyword 441 33% 50% 1081
2 MOL NEUROPSYCHIAT SECT Address 22 47% 2% 35
3 MOL NEUROPSYCHIAT BRANCH Address 15 33% 2% 36
4 METHAMPHETAMINE ABUSE Author keyword 10 52% 1% 13
5 BIOENVIRONM MED ANAT Address 9 83% 0% 5
6 SYDNOCARB Author keyword 9 83% 0% 5
7 NORMAL PATHOL CLIN PHYSIOL Address 9 22% 2% 36
8 PRENATAL DRUG Author keyword 6 71% 0% 5
9 PRENATAL METHAMPHETAMINE EXPOSURE Author keyword 6 100% 0% 4
10 INTEGRATED SUBST ABUSE PROGRAMS Address 5 12% 2% 38

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class		 LCSH search Wikipedia search
1 METHAMPHETAMINE 441 33% 50% 1081 Search METHAMPHETAMINE Search METHAMPHETAMINE
2 METHAMPHETAMINE ABUSE 10 52% 1% 13 Search METHAMPHETAMINE+ABUSE Search METHAMPHETAMINE+ABUSE
3 SYDNOCARB 9 83% 0% 5 Search SYDNOCARB Search SYDNOCARB
4 PRENATAL DRUG 6 71% 0% 5 Search PRENATAL+DRUG Search PRENATAL+DRUG
5 PRENATAL METHAMPHETAMINE EXPOSURE 6 100% 0% 4 Search PRENATAL+METHAMPHETAMINE+EXPOSURE Search PRENATAL+METHAMPHETAMINE+EXPOSURE
6 METHAMPHETAMINE INTOXICATION 4 67% 0% 4 Search METHAMPHETAMINE+INTOXICATION Search METHAMPHETAMINE+INTOXICATION
7 METHAMPHETAMINE NEUROTOXICITY 4 67% 0% 4 Search METHAMPHETAMINE+NEUROTOXICITY Search METHAMPHETAMINE+NEUROTOXICITY
8 DOPAMINERGIC NEUROTOXICITY 4 38% 0% 8 Search DOPAMINERGIC+NEUROTOXICITY Search DOPAMINERGIC+NEUROTOXICITY
9 VESICULAR MONOAMINE TRANSPORTER 2 3 20% 1% 15 Search VESICULAR+MONOAMINE+TRANSPORTER+2 Search VESICULAR+MONOAMINE+TRANSPORTER+2
10 ADRENAL AUTOTRANSPLANTATION 3 100% 0% 3 Search ADRENAL+AUTOTRANSPLANTATION Search ADRENAL+AUTOTRANSPLANTATION

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DISMUTASE TRANSGENIC MICE 108 73% 4% 82
2 ABSTINENT METHAMPHETAMINE 90 80% 3% 56
3 INDUCED DOPAMINERGIC NEUROTOXICITY 45 54% 3% 59
4 TERMINAL MARKERS 34 93% 1% 13
5 STRIATAL DOPAMINE 34 16% 9% 198
6 SUBSTITUTED AMPHETAMINES 33 44% 3% 56
7 HIGH DOSE METHAMPHETAMINE 32 85% 1% 17
8 INDUCED NEUROTOXICITY 30 14% 9% 193
9 METHAMPHETAMINE INDUCED NEUROTOXICITY 25 43% 2% 45
10 METHYLAMPHETAMINE 24 59% 1% 27

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Methamphetamine toxicity and messengers of death 2009 161 332 74%
Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findings 2013 35 189 56%
Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine 2014 14 157 44%
New insights into the mechanism of action of amphetamines 2007 239 90 46%
A review of the clinical pharmacology of methamphetamine 2009 129 147 59%
Major physical and psychological harms of methamphetamine use 2008 145 86 59%
Neurocognitive effects of methamphetamine: A critical review and meta-analysis 2007 168 170 55%
The Methamphetamine Problem in the United States 2010 76 68 62%
An Evaluation of the Evidence that Methamphetamine Abuse Causes Cognitive Decline in Humans 2013 17 108 66%
Is Cognitive Functioning Impaired in Methamphetamine Users? A Critical Review 2012 27 72 65%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 MOL NEUROPSYCHIAT SECT 22 47% 1.6% 35
2 MOL NEUROPSYCHIAT BRANCH 15 33% 1.7% 36
3 BIOENVIRONM MED ANAT 9 83% 0.2% 5
4 NORMAL PATHOL CLIN PHYSIOL 9 22% 1.7% 36
5 INTEGRATED SUBST ABUSE PROGRAMS 5 12% 1.8% 38
6 SRHSA 4 67% 0.2% 4
7 NEUROFISIOL PLASTICIDAD SIN T 4 75% 0.1% 3
8 CSAT METHAMPHETAMINE TREATMENT PROJECT 3 57% 0.2% 4
9 MATRIX COORDINATING 3 57% 0.2% 4
10 UNIT NEUROBEHAV 3 100% 0.1% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000111579 MDMA//ECSTASY//3 4 METHYLENEDIOXYMETHAMPHETAMINE
2 0.0000086517 BEHAVIORAL SENSITIZATION//BEHAV PHARMACOL GRP//CONDITIONED DRUG EFFECTS
3 0.0000075834 METH MOUTH//CHRONIC PSYCHIATRIC PATIENTS//BAKIRKOY TRAINING HOSP PSYCHIAT NEUROL NE
4 0.0000075173 SURG SCI ANESTHESIOL INTENS CARE MED//H 290 51//SURG SCI ANAESTHESIOL INTENS CARE MED
5 0.0000074601 NEUROSCI F OLORIZ//PROV DROGODEPENDENCIAS//NEUROSCI FEDERICO OLORIZ
6 0.0000066706 TETRABENAZINE//VMAT2//VESICULAR MONOAMINE TRANSPORTER
7 0.0000054914 RITALIN//METHYLPHENIDATE//METHYLPHENIDATE RITALIN
8 0.0000053131 MODAFINIL//ARMODAFINIL//INTEGRIS SLEEP DISORDERS OKLAHOMA
9 0.0000050956 IMMUNOPHARMACOTHERAPY//COCAINE HYDROLASE//NICOTINE VACCINE
10 0.0000049897 MCCS HMP PA BRANCH//FENPROPOREX//CLIN SQUADRON